sorafenib has been researched along with galactosamine in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (galactosamine) | Trials (galactosamine) | Recent Studies (post-2010) (galactosamine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 3,542 | 7 | 704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Hu, J; Liu, C; Qin, Y; Wu, W; Yin, J; Zhou, J | 1 |
1 other study(ies) available for sorafenib and galactosamine
| Article | Year |
|---|---|
N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy.
Topics: Animals; Asialoglycoproteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Galactosamine; Glucose; Glucose Oxidase; Liver Neoplasms; Lung Neoplasms; Metal-Organic Frameworks; Mice; Neoplastic Stem Cells; Sorafenib | 2022 |